Profile data is unavailable for this security.
About the company
Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.
- Revenue in USD (TTM)198.53m
- Net income in USD-63.68m
- Incorporated2014
- Employees516.00
- LocationTreace Medical Concepts Inc100 Palmetto Park PlacePONTE VEDRA 32081United StatesUSA
- Phone+1 (904) 373-5940
- Fax+1 (904) 834-7169
- Websitehttps://www.treace.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zynex Inc | 193.61m | 6.04m | 259.65m | 1.10k | 47.17 | 8.05 | 24.54 | 1.34 | 0.1734 | 0.1734 | 5.73 | 1.02 | 1.41 | 2.56 | 6.85 | 176,012.70 | 4.40 | 14.58 | 4.99 | 17.52 | 80.36 | 79.62 | 3.12 | 10.44 | 3.22 | 5.74 | 0.642 | -- | 16.54 | 42.01 | -42.91 | 0.3741 | 2.19 | -- |
| Alpha Teknova Inc | 34.94m | -34.27m | 267.05m | 210.00 | -- | 2.60 | -- | 7.64 | -0.9295 | -0.9295 | 0.9167 | 1.93 | 0.2819 | 2.36 | 6.84 | 166,381.00 | -27.65 | -- | -32.36 | -- | 22.38 | -- | -98.08 | -- | 3.28 | -29.50 | 0.144 | -- | -11.43 | -- | 22.52 | -- | -- | -- |
| Atlantic International Corp | 205.26m | -62.29m | 292.37m | 7.00 | -- | 11.49 | -- | 1.42 | -8.72 | -8.72 | 14.59 | 0.5222 | 2.91 | -- | 7.03 | 29,322,780.00 | -88.44 | -71.97 | -174.30 | -106.09 | 10.70 | 61.01 | -30.35 | -1,471.82 | -- | -1.33 | 0.7735 | -- | -100.00 | -- | -37.43 | -- | -- | -- |
| AngioDynamics, Inc. | 303.91m | -184.35m | 306.10m | 748.00 | -- | 1.49 | -- | 1.01 | -4.57 | -4.57 | 7.56 | 5.08 | 0.7148 | 2.57 | 6.30 | 406,302.10 | -43.36 | -16.38 | -54.60 | -18.70 | 50.90 | 52.95 | -60.66 | -30.49 | 1.46 | -- | 0.00 | -- | -10.28 | 2.35 | -251.53 | -- | 13.09 | -- |
| OraSure Technologies, Inc. | 273.54m | 27.03m | 321.39m | 638.00 | 11.94 | 0.7547 | 8.07 | 1.17 | 0.3611 | 0.3611 | 3.68 | 5.71 | 0.5947 | 2.72 | 6.02 | 428,738.30 | 6.00 | 0.7238 | 6.53 | 0.8212 | 44.62 | 46.94 | 10.09 | 1.13 | 10.84 | -- | 0.0018 | 0.00 | 4.64 | 17.41 | 413.17 | 82.20 | 10.18 | -- |
| Clearpoint Neuro Inc | 28.07m | -17.98m | 321.77m | 107.00 | -- | 10.01 | -- | 11.46 | -0.7062 | -0.7062 | 1.10 | 1.16 | 0.5602 | 1.31 | 8.95 | 262,327.10 | -35.89 | -34.75 | -46.51 | -39.67 | 59.85 | 64.75 | -64.06 | -76.91 | 2.31 | -- | 0.237 | -- | 16.56 | 26.64 | -34.40 | -- | 75.30 | -- |
| Pulmonx Corp | 76.58m | -57.86m | 328.88m | 279.00 | -- | 3.25 | -- | 4.29 | -1.50 | -1.50 | 1.99 | 2.58 | 0.4188 | 1.21 | 7.65 | 274,491.00 | -31.64 | -26.27 | -35.08 | -28.97 | 74.19 | 71.95 | -75.56 | -93.76 | 7.92 | -- | 0.2688 | -- | 27.98 | 27.98 | -3.26 | -- | 20.62 | -- |
| Cerus Corp | 194.51m | -24.06m | 329.83m | 288.00 | -- | 6.66 | -- | 1.70 | -0.1319 | -0.1319 | 1.07 | 0.2673 | 1.01 | 1.98 | 8.40 | 675,371.50 | -12.56 | -25.99 | -19.03 | -40.62 | 60.79 | 61.90 | -12.41 | -35.81 | 1.83 | -1.51 | 0.6244 | -- | -0.8061 | 19.69 | 12.37 | -- | 32.07 | -- |
| Sight Sciences Inc | 79.40m | -52.32m | 330.02m | 214.00 | -- | 3.24 | -- | 4.16 | -1.06 | -1.06 | 1.61 | 2.03 | 0.474 | 1.53 | 4.18 | 371,004.70 | -31.24 | -38.78 | -34.01 | -42.20 | 85.80 | 80.74 | -65.90 | -105.14 | 10.50 | -26.50 | 0.2494 | -- | 13.63 | 60.84 | 35.59 | -- | 6.77 | -- |
| Tactile Systems Technology Inc | 281.54m | 32.59m | 330.02m | 992.00 | 10.08 | 1.64 | 8.42 | 1.17 | 1.37 | 1.37 | 11.81 | 8.37 | 1.02 | 7.10 | 6.36 | 283,814.50 | 11.80 | 0.9015 | 13.87 | 1.09 | 50.63 | 49.10 | 11.58 | 0.8309 | 3.89 | -- | 0.1211 | 0.00 | 11.20 | 13.81 | 259.60 | 33.91 | -23.62 | -- |
| Treace Medical Concepts Inc | 198.53m | -63.68m | 340.80m | 516.00 | -- | 3.04 | -- | 1.72 | -1.03 | -1.03 | 3.21 | 1.80 | 0.8347 | 1.14 | 7.52 | 384,753.90 | -26.77 | -- | -31.74 | -- | 80.67 | -- | -32.08 | -- | 2.93 | -- | 0.3216 | -- | 31.92 | -- | -15.68 | -- | -- | -- |
| Nano-X Imaging Ltd | 10.13m | -57.47m | 366.19m | 164.00 | -- | 2.09 | -- | 36.16 | -0.9974 | -0.9974 | 0.1755 | 2.99 | 0.0482 | -- | 6.89 | 61,756.10 | -27.33 | -30.98 | -29.96 | -35.10 | -81.80 | -- | -567.41 | -1,527.24 | 5.09 | -- | 0.0181 | -- | 15.47 | -- | 46.33 | -- | 114.35 | -- |
| Anika Therapeutics Inc | 166.88m | -74.18m | 376.87m | 357.00 | -- | 1.80 | -- | 2.26 | -5.06 | -5.06 | 11.35 | 14.17 | 0.5642 | 1.34 | 4.73 | 467,451.00 | -25.08 | -5.41 | -27.37 | -5.87 | 62.16 | 60.70 | -44.45 | -12.60 | 3.96 | -- | 0.00 | -- | 6.67 | 9.56 | -456.34 | -- | 3.11 | -- |
| Jin Medical International Ltd | 20.13m | 2.91m | 400.76m | 245.00 | 137.34 | 15.27 | 131.49 | 19.91 | 0.0186 | 0.0186 | 0.1292 | 0.1676 | 0.5576 | 2.38 | 4.22 | 82,143.59 | 7.80 | 12.81 | 11.27 | 20.92 | 34.73 | 33.58 | 13.99 | 14.60 | 2.27 | -- | 0.2702 | 0.00 | 3.29 | -1.07 | 6.34 | -4.80 | -9.50 | -- |
| Butterfly Network Inc | 71.08m | -108.96m | 406.02m | 225.00 | -- | 2.09 | -- | 5.71 | -0.5236 | -0.5236 | 0.3407 | 0.9144 | 0.2229 | 0.6382 | 4.19 | 315,911.10 | -34.17 | -- | -39.55 | -- | 27.73 | -- | -153.29 | -- | 3.20 | -- | 0.00 | -- | -10.21 | -- | 20.76 | -- | -- | -- |
| MaxCyte Inc | 45.44m | -35.43m | 426.99m | 143.00 | -- | 1.92 | -- | 9.40 | -0.3408 | -0.3408 | 0.437 | 2.11 | 0.1739 | 0.4741 | 7.46 | 317,762.90 | -13.56 | -13.18 | -14.25 | -14.33 | 88.43 | 88.79 | -77.97 | -62.96 | 13.40 | -- | 0.00 | -- | -6.72 | 19.89 | -60.89 | -- | 39.13 | -- |
Data as of Sep 19 2024. Currency figures normalised to Treace Medical Concepts Inc's reporting currency: US Dollar USD
43.69%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Armistice Capital LLCas of 30 Jun 2024 | 5.36m | 8.62% |
| William Blair Investment Management LLCas of 30 Jun 2024 | 3.70m | 5.95% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 3.52m | 5.65% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 3.49m | 5.62% |
| Morgan Stanley & Co. LLCas of 30 Jun 2024 | 2.74m | 4.40% |
| Soleus Capital Management LP (Investment Management)as of 30 Jun 2024 | 2.37m | 3.80% |
| DWS Investments (UK) Ltd.as of 30 Jun 2024 | 2.05m | 3.29% |
| CIBC Private Wealth Advisors, Inc.as of 30 Jun 2024 | 1.93m | 3.10% |
| Geode Capital Management LLCas of 30 Jun 2024 | 1.06m | 1.71% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 957.55k | 1.54% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
